CPAP for Premature Birth
(PLANT Trial)
Trial Summary
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Do I need to stop my current medications for this trial?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the idea that CPAP for Premature Birth is an effective treatment?
The available research shows that using CPAP in the delivery room for premature infants can reduce the need for more invasive procedures like intubation and mechanical ventilation. One study found that early use of CPAP in preterm infants improved outcomes compared to these more invasive methods. Another study indicated that CPAP could lower the risk of certain breathing problems and reduce the need for intensive care in newborns delivered by cesarean section. Overall, these findings suggest that CPAP is an effective treatment for helping premature babies breathe more easily right after birth.12345
What data supports the effectiveness of the treatment Continuous Positive Airway Pressure (CPAP) for premature birth?
What safety data exists for CPAP in premature birth treatment?
The provided research does not directly address safety data for CPAP in premature birth treatment. However, it highlights the importance of adverse event reporting and monitoring in healthcare settings, which is crucial for assessing the safety of any medical intervention, including CPAP. The studies emphasize the need for effective reporting systems and standard definitions for adverse events to improve patient safety, which can be applied to CPAP treatments as well.678910
Is CPAP generally safe for use in humans?
Is Continuous Positive Airway Pressure a promising treatment for premature birth?
Yes, Continuous Positive Airway Pressure (CPAP) is a promising treatment for premature birth. It can reduce the need for more invasive procedures like intubation and mechanical ventilation in premature infants. CPAP is increasingly used for initial respiratory support in preterm infants, especially those born before 32 weeks of gestation.1231112
How is the treatment CPAP for premature birth different from other treatments?
What is the purpose of this trial?
A Pragmatic Randomized Controlled Pilot Trial to Evaluate the Impact of Early Prophylactic Continuous Positive Airway Pressure with or without Supplemental Oxygen in Spontaneously Breathing Late Preterm Newborn Infants Born by Cesarean Delivery, Compared to No Early Prophylactic Continuous Positive Airway Pressure with or without Supplemental Oxygen, on the Need for Further Respiratory Support Leading to NICU Admissions.
Research Team
Birju Shah, MD
Principal Investigator
Univeristy of Oklahoma Health Sciences Center
Eligibility Criteria
This trial is for late preterm infants born by C-section, specifically those with a gestational age between 34 and less than 37 weeks. Infants must be inborn (delivered at the hospital where the trial is conducted). Those with major congenital anomalies or conditions that severely limit life expectancy, such as pulmonary hypoplasia, cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Neonates receive either prophylactic DR-CPAP or standard care immediately after birth
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Continuous Positive Airway Pressure
- Prophylactic Delivery Room Continuous Positive Airway Pressure
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor
Indiana University
Collaborator
Pontificia Universidad Catolica de Chile
Collaborator
Columbia University
Collaborator
St. Louis University
Collaborator
University of Alberta
Collaborator